Epidemiological investigation of Kawasaki disease in Jilin province of China from 2000 to 2008

Cardiology in the Young

Volumn 20, Issue 4, 2010, Pages 426-432

  Piao, Jin Hua ^a   Jin, Lian Hua ^a   Lv, Jie ^a   Zhou, Yan ^a   Jin, Chun Ji ^b   Jin, Zheng Yong ^b  

^a JILIN UNIVERSITY   (China)

^b YANBIAN UNIVERSITY   (China)

Author keywords

Clinical features; incidence; incidence peak

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; IMMUNOLOGIC FACTOR;

ARTICLE; CARDIOVASCULAR DISEASE; CERVICAL LYMPH NODE; CHILD; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DRUG TREATMENT FAILURE; EPIDEMIOLOGICAL DATA; FEMALE; FEVER; HUMAN; INCIDENCE; INFANT; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUCOCUTANEOUS LYMPH NODE SYNDROME; ONSET AGE; PRESCHOOL CHILD; RECURRENT DISEASE; SCHOOL CHILD; SEX RATIO; SPRING; SUMMER; UNIVERSITY HOSPITAL; AGE DISTRIBUTION; COHORT ANALYSIS; RETROSPECTIVE STUDY; SEASON;

AGE DISTRIBUTION; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; CHINA; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INCIDENCE; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES; SEASONS; SEX DISTRIBUTION;

EID: 78349249093     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951110000375     Document Type: Article

References (30)

1. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long - term management of Kawasaki disease: A statement for health professionals from committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004; 114: 1708-1733.
2. Liang Y-C. Overview of Kawasaki disease in China. Chinese JPract Pediatr 1995; 10: 302-303.
3. Nakamura Y, Yanagawa H. The worldwide epidemiology of Kawasaki disease. Prog Ped Cardiol 2004; 19: 99-108.
4. Nakamura Y, Yashiro M, Uehara R, Oki L, Watanabe M, Yanagawa H. Epidemiologic features of Kawasaki disease in Japan: Result from the nationwide survey in 2005-2006. Epidemiol 2008; 18: 167-172.
5. Holman RC, Cums AT, Belay ED, Steiner CA, Schonberqer LB. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 2003; 112: 495-501.
6. Zhang Y-L, Du Z-D, Zhao D, Du J-B, Lu S, Yi J-M. Epidemiologic study on Children with Kawasaki disease in Beijing from 2000 to 2004. J Appl Clin Pediatr 2007; 22: 12-15.
7. Huang GY. Epidemiologic pictures of Kawasaki disease in Shanghai from 1998 through 2002. J Epidemiol 2006; 16: 9-14.
8. Wang D-W, Hu B-Z,Wang F-M, Zhang T-H, Kawasaki F-Z, Liu C-Y. Study on the epidemiological features of Kawasaki disease in Jiangsu. Zhonghua Liu Xing Bing Xue Za Zhi 2000; 21: 49-51.
9. Ma Y-M, Du Z-H, Li L, Shi M-R, Wan Q, Fu L-L. Study on epidemiology of Kawasaki disease in Yunan. Med Pharm Yunnan 2008; 29: 334-337.
10. Yanagawa H, Sonobe T. Changes in the diagnostic guidelines for Kawasaki disease. In: Yanagawa H, Nakamuru Y, Yashiro M, et al. (eds). Epidemiology of Kawasaki Disease: A 30-year Achievement. Shindan To Chiryosha, Tokyo, 2004; 24-32.
11. De Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998; 133: 254-258.
12. Kurotobi S, Nagai T, Kawakami N, Sano T. Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatr Int 2002; 44: 1-4.
13. Tan TH, Wong KY, Cheng TK, Heng JT. Coronary normograms and the coronaryaorta index: Objective determinants of coronary artery dilatation. Pediatr Cardiol 2003; 24: 328-335.
14. Park YW, Han JW, Park IS, et al. Epidemiologic picture of Kawasaki disease in Korea, 2000-2002. Pediatrics Int 2005; 47: 382-387.
15. Chang LY, Chang IS, Lu CY, et al. Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. J Pediatr 2004; 114: 678-682.
16. Ng YM, Sung RY, So LY, et al. Kawasaki disease in Hong Kong. Hong Kong Med J 2005; 11: 331-335.
17. Li X-H, Li X-J, Li H, Wang X-L, Xu M, Zhang T-H. Epidemiological investigation of Kawasaki disease during 1997-2000 in Sichuan Province. J Clin Pediatr 2006; 24: 306-308.
18. Jiao F, Yang L, Qiao J, et al. Epidemiological and clinical characteristics of Kawasaki disease in Shaanxi province. Zhongguo Liu Xing Bing Xue Za Zhi 2000; 21: 79-99.
19. Genizi J, Miron D, Spiegel R, Fink D, Horowitz Y. Kawasaki disease in very young infants: High prevalence of atypical presentation and coronary arteritis. Clin Pediatr 2003; 42: 263-267.
20. Huang GY. Epidemiological status of Kawasaki disease. Chinese J Pract Pediatr 2006; 21: 721-723.
21. Bronstein DE, Dille AN, Austin JP, Williams CM, Palinkas LA, Burns JC. Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998. Pediatr Infect Dis J 2000; 19: 1087-1091.
22. Zhou T-P, Liao B, Zuo T-Q. Perianal desquamation in Kawasaki disease and its diagnostic value. J Appl Clin Pediatr 1992; 7: 149.
23. Kato H. Cardiovascular complications in Kawasaki disease: Coronary artery lumen and long-term consequences. Prog Pediatr Cardiol 2004; 19: 137-145.
24. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globlin-resistant Kawasaki disease. J Pediatr 1996; 128: 146-149.
25. Sundel RP, Baker AL, Fulton DR, Newburger JW. Corticosteroids in the initial treatment of Kawasaki disease: Report of a randomized trial. J Pediatr 2003; 142: 611-616.
26. Jibiki T, Terai M, Kurosaki T, et al. Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease. Eur J Pediatr 2004; 163: 229-233.
27. Shulman ST. Is there a role for cotiscosteroids in Kawasaki disease? J Pediatr 2003; 142: 601-603.
28. Muta H, Ishii M, Furui J, Nakamura Y, Matsuishi T. Risk factors associated with need for additional intravenous gammaglobulin therapy for Kawasaki disease. Acta Pediatr 2006; 95: 189-193.
29. Newhurger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion gamma globulin as compared with four infusion in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324: 1633-1639.
30. Li Y-B, Yi Q-J, Li Q, et al. Which is the best dosage of intravenous immunoglobulin for treatment of Kawasaki disease: A comparative investigation on clinical and immunologic effects. Zhonghua Er Ke Za Zhi 1999; 37: 97-100.